April 29

2015

Q&A: Mayer Brown's Brian Nolan on strategy behind drug patent challenges

Reuters (subscription required)

Home
News
Q&A: Mayer Brown's Brian Nolan on strategy behind drug patent challenges

Related People

Brian W. Nolan

In this Q&A interview, Intellectual Property partner Brian Nolan (New York) discusses strategy behind drug patent challenges.

Related Capabilities

Practices –

Industries –

Life Sciences

News

January 23

2020

Legal 500 Asia Pacific 2020 ranks Mayer Brown in 36 categories, recognizing 24 lawyers as "Leading Individuals"

Legal 500 Asia Pacific
January 21

2020

Two Mayer Brown partners selected to IAM Global Leaders 2020 list
December 31

2019

Mayer Brown advises The Jordan Company and American Freight Group on sale to Franchise Group
December 18

2019

Gabriela Kennedy Earns Top Honors as "Outstanding Practitioner" at the 2019 Euromoney Asia Women in Business Law Awards
December 17

2019

Mayer Brown advises Avedon on the acquisition of Hauck